Conference Calls and Earnings Call Transcripts for NSE and BSE Stocks - Q3FY22

Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans - Q3FY22

announcement
Conference/Earnings Calls Alerts
907.40
-0.24%
Conference Call with Suven Pharma Management and Analysts on the acquisition of the Jasti family stake by Advent International. Listen to the transcript.
907.40
-0.24%
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our conference call intimation dated December 26, 2022, that audio recording of the conference call for the investors held on Monday, December 26, 2022, has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/news-events
100.75
-0.49%
485.05
3.11%
765.00
1.30%
321.70
0.63%
485.05
3.11%
Conference Call with Welspun Enterprises Management and Analysts on the Divestment of its Highways portfolio to Actis. Listen to the full transcript.
logo
DCX Systems Ltd.
26 Dec 2022
271.00
1.03%

Earnings Calls Podcast on